NCR2 and cancer: Loss of E-cadherin during EMT transition makes the resulting migrating cancer cells susceptible to recognition and elimination by specific subtypes of NK cells, specifically those cells that overexpress NCR2 (natural cytotoxicity-triggering receptor 2) and CD226 (123).